Tailored follow-up care for thyroid cancer survivors
Risk-stratified care for thyroid cancer survivors
This project will create personalized follow-up plans to reduce unneeded tests and worry for people who have finished treatment for thyroid cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11300961 on NIH RePORTER |
What this research studies
As a thyroid cancer survivor, I would have my long-term follow-up plan informed by real-world data from people like me in Georgia and Los Angeles County. The team will combine pathology reports, death records, patient reports, and doctor chart reviews to find who is at low versus higher risk of recurrence. They will check their findings using University of Michigan health data and then design follow-up care pathways that trade off benefits and harms. The goal is to make follow-up less burdensome for low-risk survivors while keeping careful watch for those more likely to need additional care.
Who could benefit from this research
Good fit: People who have completed initial treatment for thyroid cancer and want follow-up care that matches their personal recurrence risk are ideal candidates.
Not a fit: Patients with aggressive, advanced, or ongoing active thyroid cancer that already requires close monitoring may not avoid intensive surveillance.
Why it matters
Potential benefit: If successful, this could spare many survivors years of unnecessary tests, reduce anxiety, and focus monitoring on people who really need it.
How similar studies have performed: Some cancers have benefitted from risk-based surveillance, but applying and validating this personalized approach specifically for thyroid cancer is relatively new and needs more evidence.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Haymart, Megan Rist — University of Michigan at Ann Arbor
- Study coordinator: Haymart, Megan Rist
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.